GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹5,617 Cr | ₹5,665 Cr | ₹3,625 Cr | ₹4,401 Cr | ₹3,463 Cr |
What is the latest Revenue of GLAND PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹5,617 Cr |
| Mar2025 | ₹5,665 Cr |
| Mar2024 | ₹3,625 Cr |
| Mar2023 | ₹4,401 Cr |
| Mar2022 | ₹3,463 Cr |
How is Revenue of GLAND PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,617 Cr | -0.85 | |
| Mar2025 | ₹5,665 Cr | 56.29 | |
| Mar2024 | ₹3,625 Cr | -17.64 | |
| Mar2023 | ₹4,401 Cr | 27.08 | |
| Mar2022 | ₹3,463 Cr | - | |
Compare Revenue of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹42,907.4 Cr | 0.9% | 5.3% | 26.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 0.9% |
5.3% |
26.7% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses